Courtney M.W. Tygesson

Cooley advised TPB Acquisition Corporation I, a special purpose acquisition company sponsored by The Production Board, in its business combination agreement that will result in Lavoro Limited, a leading agricultural inputs retailer in Latin America, becoming a US publicly listed company with an implied initial enterprise value of approximately $1.2 billion.

Cooley advised NETSTREIT Corporation’s $209 million forward sale of 10,350,000 shares of common stock at a public offering price of $20.20 per share. NETSTREIT is a real estate investment trust based in Dallas, Texas, that specializes in acquiring single-tenant net lease retail properties nationwide. Partners Christina T. Roupas, Courtney M.W. Tygesson and Mischi a Marca led the Cooley team.

Cooley advised the underwriters on Arbor Realty Trust’s $123.9 million offering of 7,475,000 shares at $16.57 per share. Arbor Realty Trust is a national direct lender that provides debt capital for the multifamily loan and commercial real estate industries. Partners Daniel Goldberg, Josh Kaufman and Courtney M.W. Tygesson led the Cooley team.

Cooley advised NETSTREIT on its $230 million forward sale of 10,350,000 shares of common stock. NETSTREIT is a real estate investment trust based in Dallas, Texas, that specializes in acquiring single-tenant net lease retail properties across the US. Partners Christina Roupas, Courtney Tygesson and Mischi a Marca led the Cooley team.

Cooley advised the underwriters on DICE Therapeutics’ $234.6 million initial public offering of 13,800,000 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. BofA Securities, Inc., SVB Leerink LLC and Evercore Group L.L.C. acted as the lead book-running managers for the offering. DICE Therapeutics, whose securities now trade on the Nasdaq Global Market under the symbol “DICE,” is a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Partners Charlie Kim, Christina Roupas, Kristin VanderPas and Courtney Tygesson led the Cooley team.